Recent developments in the design of receptor specific opioid peptides
- 1 July 1989
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 9 (3), 343-401
- https://doi.org/10.1002/med.2610090306
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Immunomodulation by morphine and marijuanaLife Sciences, 1987
- A novel cyclic opioid peptide analog showing high preference for μ-receptorsBiochemical and Biophysical Research Communications, 1985
- Comparison of μ-, δ- and κ-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptidesLife Sciences, 1983
- Comparison of the action of putative endogenous κ-agonists, leumorphin and rimorphin in vitroLife Sciences, 1983
- Synthesis and analgesic properties of two leucine-enkephalin analogs containing a conformationally restrained N-terminal tyrosine residueJournal of Medicinal Chemistry, 1983
- Conformationally constrained cyclic enkephalin analogs with pronounced delta opioid receptor agonist selectivityLife Sciences, 1983
- Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: A new highly potent and fully specific agonist for opiate δ-receptorsBiochemical and Biophysical Research Communications, 1983
- Conformational restrictions of biologically active peptides via amino acid side chain groupsLife Sciences, 1982
- Tetrapeptide-amide analogues of enkephalin: The role of C-terminus in determining the character of opioid activityBiochemical and Biophysical Research Communications, 1979
- conformation and biological activities of hexapeptides related to enkephalins: Respective roles fo the ammonium and hydroxyl groups of tyrosineLife Sciences, 1979